Smith & Nephew plc (LON:SN - Get Free Report)'s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 1,094.26 ($14.80) and traded as high as GBX 1,361 ($18.41). Smith & Nephew shares last traded at GBX 1,345.50 ($18.20), with a volume of 1,841,468 shares traded.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on the company. Berenberg Bank lifted their price objective on Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the stock a "hold" rating in a research report on Thursday, August 7th. Deutsche Bank Aktiengesellschaft lifted their price objective on Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the stock a "hold" rating in a research report on Wednesday, August 6th. Finally, JPMorgan Chase & Co. lifted their price objective on Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the stock an "overweight" rating in a research report on Wednesday, August 6th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of GBX 1,379.33.
Read Our Latest Research Report on Smith & Nephew
Smith & Nephew Price Performance
The stock has a market capitalization of £15.16 billion, a PE ratio of 49.79, a PEG ratio of 0.46 and a beta of 0.62. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The company's 50 day simple moving average is GBX 1,180.15 and its 200 day simple moving average is GBX 1,103.31.
Insider Activity at Smith & Nephew
In other Smith & Nephew news, insider Deepak Nath sold 18,007 shares of Smith & Nephew stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of GBX 1,351, for a total value of £243,274.57. Also, insider David King bought 2,800 shares of the stock in a transaction on Monday, August 18th. The stock was purchased at an average cost of GBX 3,631 per share, with a total value of £101,668. 0.19% of the stock is currently owned by insiders.
About Smith & Nephew
(
Get Free Report)
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Further Reading
Before you consider Smith & Nephew, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew wasn't on the list.
While Smith & Nephew currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
